Wishing a Healthy 2016 to All Readers of Diethylstilbestrol @DES

DES induces in HBEC phenotypic changes indicative of cell transformation, associated with significant genomic alterations

DES use as a postcoital contraceptive agent is discussed

Journal of the National Cancer Institute, August 1999

Postcoital Contraception With Diethylstilbestrol

Intrauterine DES exposure and subsequent risk of breast cancer

DES still used for emergency contraception in 1995

Experimental study on relationship between exogenous estrogen and breast cancer risk

In the Netherlands, many women use a postcoital method of contraception in “emergency” situations

Effect of early life exposures on breast cancer risk

Diethylstilbestrol as a “morning after” contraceptive